Total Payments
$13,209
2024 Payments
$1,170
Companies
42
Transactions
591
Medicare Patients
10,161
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$9,668 (73.2%)
Travel$2,621 (19.8%)
Education$679.94 (5.1%)
Other$240.00 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,668 | 572 | 73.2% |
| Travel and Lodging | $2,621 | 8 | 19.8% |
| Education | $679.94 | 9 | 5.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $240.00 | 2 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $4,117 | 36 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,941 | 137 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $888.40 | 47 | $0 (2024) |
| Astellas Pharma US Inc | $766.77 | 13 | $0 (2022) |
| Amgen Inc. | $760.01 | 37 | $0 (2024) |
| PFIZER INC. | $727.84 | 99 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $670.65 | 29 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $449.46 | 34 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $373.38 | 28 | $0 (2024) |
| ShockWave Medical, Inc | $304.91 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,170 | 44 | ShockWave Medical, Inc ($304.91) |
| 2023 | $887.94 | 46 | Novartis Pharmaceuticals Corporation ($351.08) |
| 2022 | $968.67 | 40 | Novartis Pharmaceuticals Corporation ($253.96) |
| 2021 | $1,129 | 63 | Novartis Pharmaceuticals Corporation ($280.40) |
| 2020 | $2,089 | 66 | Abbott Laboratories ($1,453) |
| 2019 | $1,633 | 100 | Novartis Pharmaceuticals Corporation ($288.02) |
| 2018 | $1,684 | 139 | SANOFI-AVENTIS U.S. LLC ($311.57) |
| 2017 | $3,648 | 93 | Abbott Laboratories ($2,257) |
All Payment Transactions
591 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Transcatheter Valve Systems | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.96 | General |
| Category: Cardiovascular | ||||||
| 12/09/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $15.95 | General |
| 12/06/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $113.89 | General |
| Category: Lithoplasty | ||||||
| 12/04/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $191.02 | General |
| Category: Lithoplasty | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Cardiology | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.15 | General |
| Category: Cardiovascular | ||||||
| 10/07/2024 | Edwards Lifesciences Corporation | EVOQUE (Device) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: Transcatheter Valve Repair | ||||||
| 10/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.26 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/03/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $151.92 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/20/2024 | Edwards Lifesciences Corporation | EVOQUE (Device) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Transcatheter Valve Repair | ||||||
| 08/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/17/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Cardiology | ||||||
| 07/15/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Not Applicable | ||||||
| 07/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Cardiology | ||||||
| 07/10/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $15.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 3,166 | 5,167 | $2.4M | $952,283 |
| 2022 | 22 | 2,441 | 3,950 | $965,488 | $365,332 |
| 2021 | 25 | 2,459 | 3,598 | $943,324 | $365,580 |
| 2020 | 24 | 2,095 | 2,985 | $743,849 | $266,325 |
Total Patients
10,161
Total Services
15,700
Medicare Billing
$1.9M
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 220 | 220 | $968,000 | $383,116 | 39.6% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 220 | 440 | $462,000 | $183,658 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 346 | 777 | $215,946 | $79,839 | 37.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 300 | 1,209 | $147,646 | $52,389 | 35.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 215 | 246 | $110,994 | $42,632 | 38.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 83 | 83 | $86,069 | $33,813 | 39.3% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 37 | 38 | $76,129 | $30,342 | 39.9% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 154 | 154 | $47,740 | $19,176 | 40.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 299 | 302 | $47,297 | $18,660 | 39.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 310 | 324 | $47,277 | $18,509 | 39.1% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 79 | 79 | $42,121 | $15,675 | 37.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 83 | 166 | $36,852 | $12,652 | 34.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 68 | 78 | $30,256 | $11,933 | 39.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 33 | 74 | $18,032 | $7,549 | 41.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $15,811 | $6,103 | 38.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 37 | 85 | $15,176 | $5,589 | 36.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 37 | $13,997 | $5,502 | 39.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 263 | 425 | $13,712 | $5,259 | 38.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 26 | 26 | $11,451 | $4,685 | 40.9% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 79 | 79 | $9,796 | $3,710 | 37.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,700 | $2,314 | 40.6% |
| 93355 | Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | Facility | 2023 | 11 | 12 | $5,648 | $2,281 | 40.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 79 | 79 | $4,341 | $1,761 | 40.6% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 18 | 18 | $4,043 | $1,567 | 38.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 15 | 48 | $3,024 | $1,177 | 38.9% |
About Dr. Maged Azer, M.D
Dr. Maged Azer, M.D is a Cardiovascular Disease healthcare provider based in Orange, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992730709.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maged Azer, M.D has received a total of $13,209 in payments from pharmaceutical and medical device companies, with $1,170 received in 2024. These payments were reported across 591 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($9,668).
As a Medicare-enrolled provider, Azer has provided services to 10,161 Medicare beneficiaries, totaling 15,700 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Orange, CA
- Active Since 07/11/2006
- Last Updated 03/07/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1992730709
Products in Payments
- Mitra Clip system (Device) $2,598
- ENTRESTO (Drug) $1,609
- Tricuspid Valve Repair System (Device) $938.18
- MULTAQ (Drug) $895.99
- Repatha (Biological) $562.73
- ELIQUIS (Drug) $556.40
- JARDIANCE (Drug) $519.17
- XARELTO (Drug) $449.46
- LifeVest (Device) $373.38
- LEQVIO (Drug) $331.60
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $304.91
- Barostim Neo System (Device) $211.92
- Corlanor (Drug) $181.33
- CHANTIX (Drug) $171.55
- Livalo (Drug) $163.22
- PRADAXA (Drug) $151.48
- Valve Repair Flexible Rings and Bands (Device) $148.52
- HeartMate 3 Left Ventricular Dev (Device) $132.70
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $130.12
- PRALUENT (Drug) $117.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Orange
Morton Kern, Md, MD
Cardiovascular Disease — Payments: $411,795
Cardiovascular Disease $411,795
Michael Chan, M.d, M.D
Cardiovascular Disease — Payments: $256,557
Cardiovascular Disease $256,557
Dr. Arnold Seto, M.d, M.D
Cardiovascular Disease — Payments: $253,967
Cardiovascular Disease $253,967
Dr. Antonio Halais Frangieh, Md, Mph, MD, MPH
Cardiovascular Disease — Payments: $140,688
Cardiovascular Disease $140,688
Aidan Raney, M.d, M.D
Cardiovascular Disease — Payments: $113,297
Cardiovascular Disease $113,297
Jay Lee, M.d, M.D
Cardiovascular Disease — Payments: $89,034
Cardiovascular Disease $89,034